<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00507039</url>
  </required_header>
  <id_info>
    <org_study_id>334/06/FFM</org_study_id>
    <nct_id>NCT00507039</nct_id>
  </id_info>
  <brief_title>Safety and Repeatability of Bronchial Challenge With Grass-pollen</brief_title>
  <official_title>Repeatability of a Single Concentration and Single-step Bronchial Allergen Challenge With Grass Pollen</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is meant to establish a one-step challenge with grass-pollen in patients sensitized
      for grass-pollen. Therefore the investigators compare a multi-step challenge with
      grass-pollen with an one-step challenge in order to survey the repeatability and safety.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:

      Specific provocation with inhaled allergens is an established tool in clinical practice and
      research, supporting the understanding of pathophysiology of allergic asthma, and analysing
      the efficacy of new therapies. This study examines the repeatability of a bolus-dose
      inhalative allergen challenge with grass pollen.

      Method:

      Forty grass pollen allergics should undergo an incremental-dose grass pollen challenge to
      calculate their PD20-dose. This calculated dose will be applicated twice to analyse the
      repeatability of the bolus dose challenge. Before and twenty-four hours after the
      provocation, exhaled nitric oxid (FeNO) will be determined as a marker of bronchial
      inflammation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>repeatability of a bolus-dose inhalative allergen challenge with grass pollen</measure>
    <time_frame>feb 2007 - aug 2008</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>kappa-index of concordance: reliability of the three procedures titrated skin prick-test, incremental challenge and bolus challenge with grass pollen.</measure>
    <time_frame>feb 2007 - dec 2007</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">47</enrollment>
  <condition>Allergic Asthma</condition>
  <arm_group>
    <arm_group_label>grass allergy, bronchial challenge</arm_group_label>
    <description>subjects with known allergy against grass-pollen undergo bronchial challenges</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>inhalative grass-pollen provocation</intervention_name>
    <description>Subjects undergo allergen challenges with incremental doses of grass pollen allergen. In subjects, who develop a fall in FEV1 of more than 20%, this will be followed by two single-step challenges.</description>
    <arm_group_label>grass allergy, bronchial challenge</arm_group_label>
    <other_name>Viasys APS, Allergopharma allergen</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects undergo allergen challenges with incremental doses of grass pollen allergen. In
        those subjects, who develop a fall in FEV1 of more than 20%, this is followed by two
        single-step challenges in an interval of at least seven days.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt;12 &lt;45 years

          -  known sensitization for grass-pollen

          -  informed consent

        Exclusion Criteria:

          -  age &lt;12 &gt;45 years

          -  clinical asthma requiring regular inhalation

          -  vital capacity &lt;80%

          -  FEV1 &lt; 75%

          -  chronic disease conditions or infections

          -  pregnancy

          -  inhalative or systemic steroid use

          -  substance abuse

          -  incapability of understanding the study's purpose and performance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Zielen, M.D., Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Goethe University, Department of Pulmonology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Goethe University, Department of Pulmonology</name>
      <address>
        <city>Frankfurt</city>
        <state>Hessen</state>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Cockcroft DW, Ruffin RE, Frith PA, Cartier A, Juniper EF, Dolovich J, Hargreave FE. Determinants of allergen-induced asthma: dose of allergen, circulating IgE antibody concentration, and bronchial responsiveness to inhaled histamine. Am Rev Respir Dis. 1979 Nov;120(5):1053-8.</citation>
    <PMID>507521</PMID>
  </reference>
  <reference>
    <citation>Cockcroft DW, Murdock KY, Kirby J, Hargreave F. Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am Rev Respir Dis. 1987 Jan;135(1):264-7.</citation>
    <PMID>3800152</PMID>
  </reference>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 23, 2007</study_first_submitted>
  <study_first_submitted_qc>July 23, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 25, 2007</study_first_posted>
  <last_update_submitted>October 7, 2011</last_update_submitted>
  <last_update_submitted_qc>October 7, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 12, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johann Wolfgang Goethe University Hospital</investigator_affiliation>
    <investigator_full_name>Johannes Schulze MD</investigator_full_name>
    <investigator_title>Cosultant Pediatric Allergy and Pulmonology</investigator_title>
  </responsible_party>
  <keyword>PD20 FEV1</keyword>
  <keyword>grass pollen</keyword>
  <keyword>one-step</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

